Author

Diana Nakitto Kesi

Observed names: Diana Kesi, Diana Kesi Nakitto, Diana Nakitto, Kesi, Diana Nakitto, Nakitto-Kesi Diana

Institution: National Drug Authority

Observed institution: National Drug Authority

ORCID: 0000-0002-3989-6794

Observed ORCID: 0000-0002-3989-6794

OpenAlex ID: A5009061201

Provider perspectives on the acceptability and tolerability of dolutegravir-based anti-retroviral therapy after national roll-out in Uganda: a qualitative study

2021 · Henry Zakumumpa, Freddy Eric Kitutu, et al. · BMC Infectious Diseases · 22

Evaluation of the Clinical Use of Ceftriaxone among In-Patients in Selected Health Facilities in Uganda

2021 · Paul Kutyabami, Edson Ireeta Munanura, et al. · Antibiotics · 22

Antimicrobial consumption surveillance in Uganda: Results from an analysis of national import data for the human health sector, 2018–2021

2023 · Marion Murungi, Helen Byomire Ndagije, et al. · Journal of Infection and Public Health · 21

Prescription of Levofloxacin and Moxifloxacin in Select Hospitals in Uganda: A Pilot Study to Assess Guideline Concordance

2020 · Victoria Nambasa, Helen B. Ndagije, et al. · Antibiotics · 15

National consumption of antimicrobials intended for use in animal livestock health: a retrospective data analysis of antimicrobial imports to Uganda from 2018 to 2020

2025 · Freddy Eric Kitutu, Juliet Sanyu Namugambe, et al. · BMC Veterinary Research · 7

National-Level Consumption of Antimicrobials in the Veterinary Sector in Uganda: A Report on Analysis of Import Data for 2021

2025 · Marion Murungi, Patrick Vudriko, et al. · Antibiotics · 7

Cost and availability of selected medicines after implementation of increased import verification fees

2024 · Helen Byomire Ndagije, Diana Nakitto Kesi, et al. · BMC Health Services Research · 7

The impact of the increase in import verification fees on local production capacity of selected medicines in Uganda

2023 · Kalidi Rajab, Solomon Onen, et al. · Journal of Pharmaceutical Policy and Practice · 7

Evaluating the Glycemic Effects of Dolutegravir and Its Predictors Among People With Human Immunodeficiency Virus in Uganda: A Prospective Cohort Study

2024 · Collins Ankunda, Curthbert Agolor, et al. · Open Forum Infectious Diseases · 6

Collaborative clinical research ethics and regulatory governance in Sub-Saharan Africa: Gaps, challenges and implications

2026 · Vivian Nchanchou Mbanya, Christopher Ddamulira, et al. · Open Research Europe

Evaluation of Ceftriaxone Utilization in Three Regional Referral Hospitals in Uganda: A Prospective Multicentre Study

2026 · Edson Munanura, Margaret Ndagire, et al. · Infection and Drug Resistance

Adverse Events Among People Living With HIV Receiving Dolutegravir-Based Regimens: Findings From a 6-Month Active Pharmacovigilance Study in Uganda

2026 · Collins Ankunda, Sharon Namasambi, et al. · Open Forum Infectious Diseases

Works count: 16

Citation count: 114

H-index: 7

I10-index: 4